A Texas woman received an unexpected diagnosis of systemic mastocytosis after offering to donate a kidney to her ailing aunt, shedding light on a rare and often overlooked condition.
The woman, who lives near Houston in Spring, Texas, had experienced years of unexplained symptoms, including severe episodes of weakness, fatigue, and allergic-type reactions. Despite multiple medical evaluations, standard tests for autoimmune diseases and hormonal imbalances proved inconclusive. Her daily life gradually narrowed as she withdrew from social activities.
When her aunt required a kidney transplant but the designated donor was unable to proceed due to pregnancy, the woman volunteered to donate one of her kidneys. She traveled to Houston Methodist Hospital for the rigorous donor screening process, which included blood and urine tests as well as a CT scan of her abdomen and pelvis to assess kidney health.
While most test results were normal, radiologists identified unusual changes in the bones of her hips and pelvis. The imaging revealed diffuse haziness and patchy areas of increased density consistent with osteosclerosis—a thickening of bone tissue typically seen in patients undergoing hemodialysis for kidney failure. Concerned by this atypical finding in a healthy kidney donor candidate, Dr. Katafan Achkar, medical director of the hospital’s Living Kidney Donor Program, recommended further investigation through bone and bone marrow biopsies.
The biopsies confirmed the presence of systemic mastocytosis, a rare disorder characterized by excessive proliferation of mast cells—a type of white blood cell involved in allergic reactions and inflammation. This overgrowth causes the release of chemicals such as histamine, leading to symptoms ranging from skin flushing and itching to potentially life-threatening anaphylaxis.
Following the diagnosis, the woman sought specialized care but encountered challenges, as few local hematologists had experience with the condition. Ultimately, she found a knowledgeable physician at a clinic in nearby Kingwood who confirmed the diagnosis through detection of a non-inherited genetic mutation driving the abnormal mast cell growth.
The patient’s form of systemic mastocytosis was classified as indolent, typically manageable with targeted medications that inhibit mast cell proliferation and antihistamines to control symptoms. Despite treatment, she continues to experience episodes of weakness, shortness of breath, and abdominal pain, and was unable to proceed with kidney donation. Her aunt, unfortunately, died waiting for a transplant.
The diagnosis has helped the woman understand triggers for her reactions, including alcohol and certain foods, which she now avoids. She has also contributed to raising awareness by co-hosting a monthly podcast called “Mast Cast” alongside another systemic mastocytosis patient, sharing knowledge and support with others affected by the disease.
The case highlights the complexity of diagnosing rare diseases and underscores the importance of thorough medical evaluation when patients present with unexplained symptoms that do not fit common patterns.